Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc.
IOVA
Valuace
70
Růst
20
Zdraví
50
Cena
$ 2.48
Dnes
+0.14 (6.31%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.9B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-57%
ROA
-44%
PE
-4
PS
6
Cena 1R
2-7
⌀ Cena
2.39
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Iovance Biotherapeutics, Inc., biotechnologická společnost v klinickém stádiu, se zaměřuje na vývoj a komercializaci onkologických imunoterapeutických produktů, které využívají sílu imunitního systému pacienta k eradikaci nádorových buněk. Má šest probíhajících klinických studií fáze 2, včetně C- 144- 01, svého hlavního kandidáta na přípravek, lifileucel, pro léčbu metastazujícího melanomu; C- 145- 04 svého kandidáta na přípravek lifileucel pro recidivující, metastazující nebo perzistentní karcinom děložního hrdla; a C- 145- 03 svého kandidáta na přípravek LN- 145 pro rekurentní a/nebo metastazující skvamózní karcinom hlavy a krku. Iovance Biotherapeutics, Inc. spolupracuje a uzavírá licenční smlouvy s H. Lee Moffitt Cancer Center, M. D. Anderson Cancer Center, Ohio State University, Center hospitalier de l'Université de Montreal, Cellectis S.A. a Novartis Pharma AG. Společnost byla dříve známá jako Lion Biotechnologies, Inc. a v červnu 2017 změnila své jméno na Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. byla založena v roce 2007 a sídlí v San Carlos v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
838
Založení
2010-10-15
Adresa
825 Industrial Road
CEO
Frederick G. Vogt

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues263.5263.5164.11.20.00.00.00.00.00.00.00.00.00.00.00.00.0
Cost of Revenues7.37.3124.010.80.00.00.00.00.00.00.00.09.34.76.519.30.0
Gross Profit256.2256.240.1-9.60.00.00.00.00.00.00.00.0-9.3-4.7-6.5-19.30.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues86.867.560.049.373.758.631.10.70.50.5
Cost of Revenues-100.51.456.749.745.539.831.47.314.14.3
Gross Profit187.366.03.3-0.428.218.7-0.3-6.5-13.6-3.9
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0344.1294.8259.0201.7166.099.871.628.015.52.71.31.71.80.0
Selling General & Admin Expenses0.00.00.0106.9104.183.760.240.828.421.325.612.49.34.76.519.30.0
Depreciation & Amortization35.935.943.633.121.114.01.11.21.01.01.01.00.10.00.00.00.1
Total Operating Expenses659.6659.6435.4451.0398.9342.7261.9206.9128.392.953.627.912.022.68.121.10.8
Operating Income-403.4-403.4-395.3-460.6-398.9-342.7-261.9-206.9-128.3-92.9-53.6-27.9-12.0-22.6-8.1-21.2-0.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.087.587.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.020.227.0
Depreciation & Amortization3.99.011.911.111.711.110.99.99.79.9
Total Operating Expenses260.8160.9117.1120.8114.7107.8101.7111.2107.7114.5
Operating Income-73.5-94.9-113.8-121.2-86.6-89.1-101.9-117.7-121.3-118.4
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income14.60.020.313.03.00.50.00.00.00.80.70.20.00.00.00.00.0
Interest Expense0.00.00.00.03.00.00.00.00.00.00.00.20.00.42.40.20.0
Other Expense10.310.320.313.03.00.52.49.34.70.80.70.20.0-2.38.6-4.5-0.8
IBT-393.0-393.0-375.0-447.5-395.9-342.3-259.6-197.6-123.6-92.1-52.9-27.7-12.0-25.4-3.3-25.7-1.6
Income Tax Expense-2.1-2.1-2.8-3.5-6.0-14.4-2.4-10.54.7-1.0-1.0-1.00.00.42.44.60.8
Net Income-391.0-391.0-372.2-444.0-389.9-327.8-257.2-187.1-123.6-92.1-52.9-27.7-12.0-25.4-3.3-25.7-1.6
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income7.30.04.13.29.64.03.43.33.13.4
Interest Expense0.00.00.00.00.00.00.00.03.50.0
Other Expense1.71.24.13.29.64.03.43.33.13.4
IBT-71.7-93.7-109.7-118.0-77.0-85.1-98.6-114.4-118.1-115.0
Income Tax Expense0.2-2.42.0-1.81.6-1.5-1.5-1.4-1.8-1.2
Net Income-71.9-91.3-111.7-116.2-78.6-83.5-97.1-113.0-116.4-113.8
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.89$-2.45$-2.14$-1.86$-1.50$-1.27$-1.41$-0.96$-0.62$-0.48$-2.60$-4.14$-33.84$-2.46
EPS Diluted$0.00$0.00$0.00$-1.89$-2.45$-2.14$-1.86$-1.50$-1.27$-1.41$-0.96$-0.62$-0.48$-2.60$-4.14$-33.84$-2.46
Shares Outstanding407.0357.3289.9235.1159.3153.4138.3124.397.365.255.344.425.09.80.80.80.7
Diluted Shares Outstanding407.0357.3289.9235.1159.3153.4138.3124.397.365.255.344.425.09.80.80.80.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.45$-0.46
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.45$-0.46
Shares Outstanding407.0364.0334.5322.9304.9303.3284.8266.2256.0245.8
Diluted Shares Outstanding407.0364.0334.5322.9304.9303.3284.8266.2256.0245.8
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents228.8115.7114.9231.778.267.314.082.2145.4166.5103.744.919.70.00.51.3
Short Term Investments183.9208.1165.0240.1426.2562.1293.1386.40.059.890.10.00.00.00.00.0
Total Cash & ST Investments412.6323.8279.9471.8596.0629.4307.1468.5145.4166.5103.744.919.70.00.51.3
Accounts Receivable31.669.30.20.00.00.00.00.00.00.00.00.00.00.00.00.0
Inventory27.951.510.40.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Current Assets10.212.417.57.33.56.79.46.93.93.00.30.10.20.00.00.0
Total Current Assets482.3457.0307.8471.8508.0636.1312.5475.4149.3169.5104.045.019.80.00.51.3
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents158.1132.5171.7115.7164.2228.8134.2114.9267.7230.0
Short Term Investments142.7168.7188.0208.1233.3183.9222.0165.093.720.9
Total Cash & ST Investments300.8301.2359.7323.8397.5412.6356.2279.9361.4250.9
Accounts Receivable66.859.970.969.355.831.60.20.20.00.0
Inventory51.749.865.551.538.627.917.610.49.29.7
Other Current Assets9.811.516.512.46.710.211.517.512.028.5
Total Current Assets429.1422.5512.6457.0498.6482.3385.5307.8382.6274.9
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment180.1164.3176.5178.2169.9113.919.22.72.52.41.71.50.00.00.00.2
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets295.3282.4229.30.00.00.00.00.00.00.00.00.00.00.00.00.2
Long-Term Investments6.40.00.00.091.60.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.36.766.7-171.87.918.412.92.83.60.00.00.00.00.00.0-0.2
Total Long-Term Assets482.1453.4472.56.4269.4132.432.15.46.12.41.71.50.00.00.00.2
Total Assets964.3910.4780.4664.0777.3768.5344.7480.8155.4171.9105.746.519.90.00.61.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment175.4172.4162.5164.3179.3180.1183.3176.5179.4180.2
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets285.2296.3285.4282.4306.6295.3294.3229.3223.6235.5
Long-Term Investments6.00.00.00.06.46.40.066.466.466.4
Other Long-Term Assets9.316.36.26.70.30.36.70.366.766.7
Total Long-Term Assets475.9484.9454.1453.4492.5482.1484.3472.5469.7482.4
Total Assets904.9907.4966.7910.4991.1964.3869.8780.4852.3757.3
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable20.427.533.126.627.413.515.62.71.20.91.01.20.41.10.20.0
Short-Term Debt11.412.915.612.65.16.37.30.00.00.00.00.00.06.55.00.0
Other Current Liabilities61.881.961.652.356.835.116.311.78.74.10.70.41.93.87.90.8
Current Liabilities93.6122.3110.391.589.254.939.114.49.95.01.61.72.311.313.30.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable31.232.028.527.531.720.425.733.119.331.2
Short-Term Debt7.38.19.512.911.611.411.115.620.921.7
Other Current Liabilities87.389.184.781.974.861.846.461.650.735.8
Current Liabilities125.8129.2122.7122.3118.193.683.2110.391.088.6
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt1.045.468.184.466.545.44.20.00.00.00.00.00.00.00.00.0
Capital Leases69.257.374.984.470.551.711.50.00.00.00.00.00.00.00.00.0
Def. Tax Liability31.932.317.30.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities195.8200.0195.7164.3155.7112.045.714.69.95.01.61.72.311.313.30.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt45.245.144.245.467.470.273.368.169.069.8
Capital Leases0.052.252.757.377.969.283.467.178.579.7
Def. Tax Liability31.734.732.032.332.231.933.317.318.320.2
Total Liabilities202.7208.9198.9200.0217.7195.8189.8195.7178.3178.7
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings-2,222.5-2,384.6-2,012.4-1,568.3-1,172.4-830.2-570.6-372.8-249.2-157.1-104.2-76.6-64.5-30.7-27.4-1.7
Comprehensive Income0.5-1.02.5-0.9-0.60.00.20.00.00.00.0-0.10.00.00.00.0
Total Common Equity768.5710.4584.6499.6621.7656.5299.0466.2145.5166.9104.044.817.6-11.3-12.80.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-2,703.6-2,612.4-2,500.7-2,384.6-2,306.0-2,222.5-2,125.4-2,012.4-1,896.0-1,782.2
Comprehensive Income16.120.96.3-1.016.20.50.12.5-9.10.3
Total Common Equity702.3698.5767.9710.4773.5768.5680.0584.6674.0578.6
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt81.758.375.984.471.551.711.50.00.00.00.00.00.06.55.00.0
Book Value768.5710.4584.6499.6621.7656.5299.0466.2145.5166.9104.044.817.6-11.3-12.80.6
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value702.3698.5767.9710.4773.5768.5680.0584.6674.0578.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-440.2-391.0-372.2-444.0-395.9-342.3-259.6-197.6-123.6-92.1-52.9-27.7-12.0-25.4-3.3-25.7-1.6
Depreciation & Amortization40.434.543.633.121.114.01.11.21.01.01.01.00.10.00.00.00.1
Stock-Based Compensation77.961.6109.662.684.069.840.924.320.012.018.90.00.00.00.00.00.0
Change Working Capital-53.5-24.3-122.6-6.5-2.924.63.010.02.70.40.4-0.2-0.5-0.34.50.40.0
Change In Accounts Receivable-31.6-13.1-69.2-0.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Change In Accounts Payable-14.5-6.7-7.84.85.97.0-3.012.71.50.4-0.30.0-0.4-0.50.90.40.0
Change In Inventories-16.2-14.2-39.9-10.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items145.018.9-8.6-3.50.96.07.66.6-1.30.0-0.18.53.822.0-3.419.10.9
Cash from Operations-388.80.00.0-361.8-292.8-227.9-205.1-158.9-101.2-78.7-32.7-18.4-8.6-3.7-2.2-6.2-0.6
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-71.9-91.3-111.7-116.2-78.6-83.5-97.1-113.0-116.4-113.8
Depreciation & Amortization17.911.711.911.111.711.110.99.99.79.9
Stock-Based Compensation11.80.014.922.90.031.030.517.214.415.8
Change Working Capital-7.3-8.59.2-17.6-38.0-13.3-38.7-32.511.95.9
Change In Accounts Receivable-15.7-6.811.0-1.6-13.6-24.2-31.4-0.1-0.10.0
Change In Accounts Payable-5.2-4.40.92.1-6.114.4-10.4-5.811.4-9.8
Change In Inventories-4.0-3.26.9-14.0-13.5-10.9-8.9-6.7-0.90.4
Other Non-cash Items-3.211.86.2-2.030.0-2.7-2.5-2.4-1.8-0.7
Cash from Operations0.00.00.00.00.00.00.00.0-84.0-84.1
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-11.7-33.8-11.1-22.3-20.4-37.6-46.8-6.9-1.2-1.0-1.5-1.1-1.60.00.00.00.0
Acquisitions-55.70.0-52.6-212.60.00.00.00.00.00.00.019.90.00.00.00.00.0
Investments-416.7-318.7-460.8-205.9-245.8-725.2-947.7-417.7-426.10.0-110.2-160.60.00.00.00.00.0
Sales of Investment261.0400.0428.0285.6522.7762.9676.6514.641.059.7120.770.60.00.00.00.00.0
Other Investing Activities-155.70.00.00.00.00.00.00.00.00.00.0-19.90.00.00.0-0.10.0
Cash from Investing-223.10.00.0-155.2256.50.1-317.990.0-386.358.78.9-91.2-1.60.00.0-0.10.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-9.3-10.8-7.5-6.2-4.2-2.3-0.4-4.2-3.5-3.6
Acquisitions0.00.00.00.00.00.00.0-52.60.3-3.4
Investments-59.9-92.1-68.7-97.9-88.2-156.5-74.3-141.8-107.6-93.0
Sales of Investment70.0120.090.0120.0116.0110.0115.087.038.021.0
Other Investing Activities0.00.00.00.00.00.00.00.0-69.6-72.1
Cash from Investing0.00.00.00.00.00.00.00.0-72.8-79.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Debt Issued1.058.3-17.6-8.612.919.940.211.50.00.00.00.00.0-6.51.55.00.0
Issuance of Common Stock556.40.00.0463.3189.5203.2567.00.0398.853.795.768.332.27.10.30.91.9
Repurchase of Common Stock-6.30.00.00.01.71.60.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0-49.50.00.00.00.00.00.0
Other Financing Activities-6.30.00.0-0.3-1.034.59.46.125.55.050.710.03.216.21.54.60.0
Cash from Financing550.20.00.0463.0190.2239.3576.46.1424.358.796.978.335.523.31.75.51.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued52.5-0.7-0.6-4.5-20.7-2.7-2.78.5-2.6-2.2
Issuance of Common Stock0.00.00.00.00.00.00.00.00.0203.2
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.01.0-0.4
Cash from Financing0.00.00.00.00.00.00.00.01.0202.8
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-1.347.4-59.3-56.8153.811.553.4-62.7-63.238.773.1-31.325.219.7-0.5-0.81.3
Closing Cash Balance228.8169.1122.1181.3238.284.372.919.482.2145.4106.713.644.919.70.00.51.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash5.025.7-39.656.0-48.5-64.694.5-40.7-152.837.7
Closing Cash Balance169.1158.1138.4178.0115.7170.5235.1140.6114.9267.7
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-400.5-336.2-364.0-384.1-313.2-265.5-251.9-165.8-102.4-79.7-34.2-19.5-10.2-3.7-2.2-6.2-0.6
Real Free Cash Flow-478.3-397.8-473.7-446.7-397.2-335.3-292.8-190.1-122.5-91.7-53.1-19.5-10.2-3.7-2.2-6.2-0.6
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-61.9-89.5-74.9-109.9-77.5-61.3-98.9-126.5-87.5-87.7
Real Free Cash Flow-73.7-89.5-89.9-132.8-77.5-92.3-129.3-143.6-101.9-103.5
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-3.8-9.5-1.4
P/S5.7254.49.4
P/B2.14.75.2
P/FCF-3.9-9.3-1.5
Market cap$0.9$1.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets5.8 %1382.4 %0 %
Debt to Income-13.4 %-4 %0 %
Debt to Free cash flow-13.6 %-395.2 %0 %
Interest expense percentage0 %-2.6 %44.7 %
Current ratio3.4 14.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-55.7 %-35.9 %0 %
ROA-43.2 %-2372.6 %0 %
CapEx to Revenue11.5 %231.5 %0 %
RaD to Revenue0 %3733.1 %0 %
ROEM314,441.5 692.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin38.8 %-99.1 %68.7 %
Operating margin-166.3 %-4980.7 %35.5 %
Net margin-158.8 %-4773.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.3 %0 %
Dividend payout percentage0 %-4.5 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding364.0 mil 101.9 mil
Employee count0.8 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader